Oct 2026· European Journal of Neuroscience· Vol 64· 0 citations· 88 references
Medicine
TL;DR
Findings highlight candidate structural determinants for future experimental studies of GBA1-associated neurodegeneration and identify evolutionarily constrained features of GBA1 that may influence its interaction with α-synuclein (SNCA) and thereby contribute to PD pathogenesis.
Abstract
GBA1 encodes lysosomal acid β‐glucosidase (glucocerebrosidase [GCase]), a key lysosomal enzyme and one of the most important genetic factors in Parkinson's disease (PD). Yet how different GBA1 variants influence PD‐related molecular pathology remains incompletely understood. Here, we integrated phylogenetic, comparative sequence, structural, docking, and molecular dynamics analyses to identify evolutionarily constrained features of GBA1 that may influence its interaction with α‐synuclein (SNCA) and thereby contribute to PD pathogenesis. Phylogenetic reconstruction indicated that GBA1 originated early in bilaterian evolution and was maintained as a single‐copy gene in the sampled taxa, consistent with strong functional constraint. Sequence‐based analyses across sarcopterygian lineages further supported pervasive purifying selection, especially within the TIM barrel catalytic domain. Comparative structural analyses highlighted a conformationally sensitive segment spanning Residues 379–389, which includes catalytic and neighboring residues and showed recurrent involvement in both mammalian evolution and PD‐associated mutant proteins. Docking and molecular dynamics simulations of wild‐type and mutant GBA1–SNCA complexes indicated that PD‐associated substitutions can remodel hydrogen‐bond networks and influence the conformational landscape of the GBA1–SNCA complex in a mutation‐specific manner. Although no statistically significant differences in global structural or energetic properties were detected, individual variants exhibited distinct patterns of conformational deviation, flexibility, and interaction dynamics relative to wild type. In particular, Residues 387–389 emerged as part of a structurally responsive region linked to altered GBA1–SNCA association. Together, these findings highlight candidate structural determinants for future experimental studies of GBA1‐associated neurodegeneration.
Overall, these findings support an effect of the five variants on α-galactosidase A structure and function and highlight the value of integrating clinical, genetic, biochemical, and computational data for variant interpretation.
Monia Anania, V. Pagliardini, Marco Spada et al.· International Journal of Mol...· 0 citations
These findings support a model in which the NTE and CTE act as intramolecular determinants of PINK1 kinase stability and suggest that vertebrate PINK1 has evolved an increased dependence on the mitochondrial import machinery to maintain a functional state.
Tara Shomali, S. Veyron, J. Trempe· bioRxiv· 0 citations
Mutations in the GDAP1 gene, which encodes the ganglioside-induced differentiation-associated protein 1 (GDAP1)—a member of the detoxifying glutathione S-transferase (GST) superfamily—cause Charcot–Marie–Tooth disease (CMT) a genetically heterogeneous group of inherited neuropathies. This mini review correlates the cli...
V. Bunik, A. Emelyanova· Frontiers in Medicine· 0 citations
PURPOSE
CDK19 (HGNC:19338) is a Mediator-associated kinase that regulates transcription during neurodevelopment. Although CDK19 variants have been linked to neurodevelopmental disorders, the full phenotypic spectrum and underlying pathogenic mechanisms remain incompletely defined. We aimed to further characterize clini...
Hyun Yong Koh, R. Sahu, Sung Dae Kim et al.· Genetics in Medicine· 0 citations
Parkinson’s Disease (PD) is a complex progressive neurodegenerative disease with certain cases exhibiting non-idiopathic forms. Understanding this allows for a better understanding about the disease and treatment options. The 2 main genetic forms of PD are mutations in the Glucosylceramidase Beta 1 (GBA1) and Leucine-R...
Nikhil Rahul· Proceedings of the OJSS Virt...· 0 citations
PRKN-associated parkinsonism represents one of the most prominent genetic causes of early-onset
autosomal recessive parkinsonism. This study reports an exploratory in silico characterization of the
human PRKN gene and a theoretical CRISPR/Cas9 gene editing design for exon disruption. Using
genomic and protein databases...
Arya Rajmohan· American Journal of Student...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.